UMIN-CTR Clinical Trial

Recruitment status No longer recruiting
Unique ID issued by UMIN UMIN000016999
Receipt No. R000018189
Scientific Title Prospective cohort study of lung oligometastasis of breast cancer
Date of disclosure of the study information 2015/03/31
Last modified on 2020/10/03 (Ver. 3)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Prospective cohort study of lung oligometastasis of breast cancer
Acronym SBP-06
Scientific Title Prospective cohort study of lung oligometastasis of breast cancer
Scientific Title:Acronym SBP-06
Region
Japan

Condition
Condition Breast Cancer
Classification by specialty
Hematology and clinical oncology Breast surgery
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 Prospective analysis of diagnosis, treatment strategy and prognosis of lung oligometastasis of breast cancer
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Overall survival of lung oligometastasis of breast cancer
Key secondary outcomes Efficacy and safety of surgery for lung oligometastasis of breast cancer

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
18 years-old <=
Age-upper limit
80 years-old >=
Gender Male and Female
Key inclusion criteria (1)First metastasis after curable breast cancer surgery
(2)under 3 lung metastasesdiagnosed by CT, PET/CT or biposy.
(3)only lung metastasis
(4)ER, PgR and HER2 expression were diagnosed by primary breast cancer tumor
Key exclusion criteria none
Target sample size 80

Research contact person
Name of lead principal investigator
1st name Tadahiko
Middle name
Last name Shien
Organization Okayama University Hospital
Division name Breast and Endocrine surgery
Zip code 700-8558
Address 2-5-1 Shikata-cho, Kita-ku, Okayama
TEL +81862357265
Email tshien@md.okayama-u.ac.jp

Public contact
Name of contact person
1st name Tadahiko
Middle name
Last name Shien
Organization Setouchi Breast Project
Division name Crinical trial committiee
Zip code 700-8558
Address 2-5-1 Shikata-cho. Kita-ku, Okayama
TEL 086-235-7265
Homepage URL
Email tshien@md.okayama-u.ac.jp

Sponsor
Institute Setouchi Breast Project
Institute
Department

Funding Source
Organization Setouchi Breast Project
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Okayama University Hospital, Ethics Committee
Address 1-5-2 Shikata-cho, Kita-ku
Tel 086-235-7265
Email tshien@md.okayama-u.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2015 Year 03 Month 31 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status No longer recruiting
Date of protocol fixation
2014 Year 10 Month 13 Day
Date of IRB
2014 Year 10 Month 13 Day
Anticipated trial start date
2014 Year 10 Month 13 Day
Last follow-up date
2019 Year 09 Month 30 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information Diagnosis, treatment strategy and prognosis of lung oligometastasis of breast cancer

Management information
Registered date
2015 Year 03 Month 31 Day
Last modified on
2020 Year 10 Month 03 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000018189